BDSX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Biodesix Inc (BDSX) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive indicators such as hedge fund buying and revenue growth, the lack of strong technical signals, insider selling, and weak financial performance make it prudent to hold off on purchasing this stock now.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), but the MACD is below zero and negatively contracting, indicating weak momentum. RSI is neutral at 61.132, and the stock is trading near its resistance level (R1: 11.309). Overall, the technical indicators do not provide a strong buy signal.
Hedge funds are significantly increasing their buying activity, with a 1991.20% increase over the last quarter. Revenue grew by 19.93% YoY in Q3 2025, and gross margin improved by 5.40% YoY to 81.14%.
Insiders are selling, with a 263.88% increase in selling activity over the last month. The company's net income dropped by 15.03% YoY, and EPS declined by 17.14% YoY. No recent news or congress trading data is available to support a positive sentiment.
In Q3 2025, revenue increased to $21.77M, up 19.93% YoY. However, net income dropped to -$8.72M (-15.03% YoY), and EPS fell to -1.16 (-17.14% YoY). Gross margin improved to 81.14%, up 5.40% YoY, but the overall financial performance remains weak due to declining profitability.
No recent analyst ratings or price target changes are available for BDSX.
